Impact of Being Eligible for Type 2 Diabetes Treatment on All-Cause Mortality and Cardiovascular Events: Regression Discontinuity Design Study

MLA

Petersen I, et al. “Impact of Being Eligible for Type 2 Diabetes Treatment on All-Cause Mortality and Cardiovascular Events: Regression Discontinuity Design Study.” Clinical Epidemiology, June 2020, pp. 569–77. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doajarticles..fddc5caec149fab873248f5c4c3d049a&authtype=sso&custid=ns315887.

APA

Petersen I, Nicolaisen SK, Ricciardi F, Sharma M, Thomsen RW, Baio G, & Pedersen L. (2020). Impact of Being Eligible for Type 2 Diabetes Treatment on All-Cause Mortality and Cardiovascular Events: Regression Discontinuity Design Study. Clinical Epidemiology, 569–577.

Chicago

Petersen I, Nicolaisen SK, Ricciardi F, Sharma M, Thomsen RW, Baio G, and Pedersen L. 2020. “Impact of Being Eligible for Type 2 Diabetes Treatment on All-Cause Mortality and Cardiovascular Events: Regression Discontinuity Design Study.” Clinical Epidemiology, June, 569–77. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doajarticles..fddc5caec149fab873248f5c4c3d049a&authtype=sso&custid=ns315887.